Processa Pharmaceuticals Inc (NAS:PCSA)
$ 2.18 +0.040 (+1.87%) Market Cap: 6.09 Mil Enterprise Value: 551,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Processa Pharmaceuticals Inc Acquisition of Vidya Therapeutics Transcript

Jul 29, 2026 / 12:30 PM GMT
Release Date Price: $2.03 (-33.44%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PCSA.OQ - Processa Pharmaceuticals Inc
Processa Pharmaceuticals Inc Acquisition of Vidya Therapeutics
Jul 29, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. My name is Demi and I'll be your conference operator today. At this time, I would like to welcome everyone to the Procesa Pharmaceuticals announces acquisition of Vidia Therapeutics.

All lines have been placed on mute to prevent any background noise.

I would now like to turn the conference over to George Ng, CEO. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for joining us for our announcement of Processa's acquisition of Vidya Therapeutics and the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot